Nephrocaps

Role

Indications

Reactions

Secondary

Hyperparathyroidism Secondary	50.0%
Nephrogenic Anaemia	50.0%

Convulsion	50.0%
Product Quality Issue	50.0%

Concomitant

Drug Use For Unknown Indication	36.6%
Product Used For Unknown Indication	26.2%
Nuclear Magnetic Resonance Imaging	10.8%
Angiogram	4.0%
Nuclear Magnetic Resonance Imaging Brain	2.8%
Multiple Myeloma	2.6%
Pain	2.4%
Peritoneal Dialysis	2.4%
Hypertension	1.7%
Anaemia	1.5%
Renal Failure Chronic	1.5%
Nuclear Magnetic Resonance Imaging Abdominal	1.1%
Thrombosis Prophylaxis	1.0%
Haemodialysis	0.9%
Imaging Procedure	0.9%
Dialysis	0.8%
Nausea	0.7%
Vitamin Supplementation	0.7%
Depression	0.7%
Chemotherapy	0.6%

Vomiting	15.2%
Nephrogenic Systemic Fibrosis	11.9%
Skin Tightness	10.5%
Peritonitis Bacterial	5.6%
Weight Decreased	5.4%
Skin Induration	4.9%
Cardiac Arrest	4.7%
Nephrogenic Fibrosing Dermopathy	4.4%
Peritonitis	4.0%
Death	3.7%
Renal Failure Chronic	3.5%
Sepsis	3.5%
Thrombocytopenia	3.5%
Wound Secretion	3.5%
Nausea	2.8%
Ventricular Tachycardia	2.8%
Oedema Peripheral	2.6%
Pain	2.6%
Unresponsive To Stimuli	2.3%
Urinary Tract Infection	2.3%